UBS Maintains Sell on ASGN, Lowers Price Target to $35

Benzinga Newsdesk www.benzinga.com Negative 86.8%

Neg 86.8% Neu 0% Pos 0%

UBS analyst Kevin Mcveigh maintains ASGN (NYSE:ASGN) with a Sell and lowers the price target from $39 to $35.

Comments

No comments yet. Be the first!